Cargando…
Author Correction: Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
Autores principales: | Peng, Wei, Zhou, Zhaofei, Zhong, Yuejiao, Sun, Yan, Wang, Yajing, Zhu, Zili, Jiao, Wenxuan, Bai, Man, Sun, Jing, Lu, Jianwei, Yin, Hanwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560690/ https://www.ncbi.nlm.nih.gov/pubmed/33057092 http://dx.doi.org/10.1038/s41598-020-70071-5 |
Ejemplares similares
-
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
por: Peng, Wei, et al.
Publicado: (2019) -
Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer
por: Zhong, Yuejiao, et al.
Publicado: (2020) -
Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway
por: Jiao, Wenxuan, et al.
Publicado: (2021) -
Clinical application of thioredoxin reductase as a novel biomarker in liver cancer
por: Wu, Xuping, et al.
Publicado: (2021) -
Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer
por: Zhu, Yinxing, et al.
Publicado: (2023)